These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 6257786

  • 1. Relative lack of Epstein Barr virus (EBV) receptors on B cells from persistently EBV seronegative adults.
    Gervais F, Wills A, Leyritz M, Lebrun A, Joncas JH.
    J Immunol; 1981 Mar; 126(3):897-900. PubMed ID: 6257786
    [Abstract] [Full Text] [Related]

  • 2. Heterogeneity of EBV-transformable human B lymphocyte populations.
    Chan MA, Stein LD, Dosch HM, Sigal NH.
    J Immunol; 1986 Jan; 136(1):106-12. PubMed ID: 2999241
    [Abstract] [Full Text] [Related]

  • 3. Epstein Barr virus binding induces internalization of the C3d receptor: a novel immunotoxin delivery system.
    Tedder TF, Goldmacher VS, Lambert JM, Schlossman SF.
    J Immunol; 1986 Aug 15; 137(4):1387-91. PubMed ID: 3016095
    [Abstract] [Full Text] [Related]

  • 4. T cell-mediated immunoregulation of Epstein Barr virus- (EBV) induced B lymphocyte activation in EBV-seropositive and EBV-seronegative individuals.
    Tosato G, Magrath IT, Blaese RM.
    J Immunol; 1982 Feb 15; 128(2):575-9. PubMed ID: 6274959
    [Abstract] [Full Text] [Related]

  • 5. Impairment of T-cell control of Epstein-Barr virus infected B-cells in patients with adult T-cell leukemia.
    Katsuki T, Yamaguchi K, Matsuoka Y, Hinuma Y.
    AIDS Res; 1986 Dec 15; 2 Suppl 1():S125-30. PubMed ID: 3030343
    [Abstract] [Full Text] [Related]

  • 6. Various responses of lymphocytes to Epstein-Barr virus in patients with common variable immunodeficiency.
    Kondo N, Inoue R, Orii T.
    J Clin Lab Immunol; 1992 Dec 15; 37(4):183-9. PubMed ID: 1285068
    [Abstract] [Full Text] [Related]

  • 7. Epstein-Barr virus-induced lymphoblastoid cell lines from seropositive adult donors and their HLA-antigens.
    Akiyama N, Ohsawa N, Kusaba R, Inou T, Takada M.
    Jpn J Exp Med; 1981 Feb 15; 51(1):1-7. PubMed ID: 6273617
    [Abstract] [Full Text] [Related]

  • 8. [Analysis of Epstein-Barr virus transformation of human lymphocytes: susceptibility of B lymphocyte subpopulations and differentiation stage of the transformed cells].
    Koizumi S.
    Hokkaido Igaku Zasshi; 1985 Sep 15; 60(5):724-34. PubMed ID: 3000906
    [Abstract] [Full Text] [Related]

  • 9. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
    Niller HH, Wolf H, Minarovits J.
    Autoimmunity; 2008 May 15; 41(4):298-328. PubMed ID: 18432410
    [Abstract] [Full Text] [Related]

  • 10. In vitro regulation of IgA subclass production. III. Selective transformation of IgA1 producing cells by Epstein-Barr virus.
    Conley ME, Chan MA, Sigal NH.
    J Immunol; 1987 Mar 01; 138(5):1403-7. PubMed ID: 3027178
    [Abstract] [Full Text] [Related]

  • 11. B lymphoblast antigen (BB-1) expressed on Epstein-Barr virus-activated B cell blasts, B lymphoblastoid cell lines, and Burkitt's lymphomas.
    Yokochi T, Holly RD, Clark EA.
    J Immunol; 1982 Feb 01; 128(2):823-7. PubMed ID: 6274961
    [Abstract] [Full Text] [Related]

  • 12. Antigen presentation by human B cells: T cell proliferation induced by Epstein Barr virus B lymphoblastoid cells.
    Issekutz T, Chu E, Geha RS.
    J Immunol; 1982 Oct 01; 129(4):1446-50. PubMed ID: 6286767
    [Abstract] [Full Text] [Related]

  • 13. MYC overexpression imposes a nonimmunogenic phenotype on Epstein-Barr virus-infected B cells.
    Staege MS, Lee SP, Frisan T, Mautner J, Scholz S, Pajic A, Rickinson AB, Masucci MG, Polack A, Bornkamm GW.
    Proc Natl Acad Sci U S A; 2002 Apr 02; 99(7):4550-5. PubMed ID: 11917131
    [Abstract] [Full Text] [Related]

  • 14. Comparative immunophenotypic features of EBV-positive and EBV-negative atypical lymphocytosis.
    Hudnall SD, Patel J, Schwab H, Martinez J.
    Cytometry B Clin Cytom; 2003 Sep 02; 55(1):22-8. PubMed ID: 12949956
    [Abstract] [Full Text] [Related]

  • 15. Epstein-Barr virus preferentially induces proliferation of primed B cells.
    Crain MJ, Sanders SK, Butler JL, Cooper MD.
    J Immunol; 1989 Sep 01; 143(5):1543-8. PubMed ID: 2547870
    [Abstract] [Full Text] [Related]

  • 16. Blastogenic response of purified human T-lymphocyte populations to Epstein-Barr virus (EBV).
    Gergely P, Ernberg I, Klein G, Steinitz M.
    Clin Exp Immunol; 1977 Dec 01; 30(3):347-53. PubMed ID: 203426
    [Abstract] [Full Text] [Related]

  • 17. Clinicopathological states of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disorders (severe chronic active EBV infection) of children and young adults.
    Suzuki K, Ohshima K, Karube K, Suzumiya J, Ohga S, Ishihara S, Tamura K, Kikuchi M.
    Int J Oncol; 2004 May 01; 24(5):1165-74. PubMed ID: 15067338
    [Abstract] [Full Text] [Related]

  • 18. Epstein-Barr virus-associated peripheral T-cell and NK-cell proliferative disease/lymphoma: clinicopathologic, serologic, and molecular analysis.
    Mitarnun W, Suwiwat S, Pradutkanchana J, Saechan V, Ishida T, Takao S, Mori A.
    Am J Hematol; 2002 May 01; 70(1):31-8. PubMed ID: 11994979
    [Abstract] [Full Text] [Related]

  • 19. Epstein-barr virus-associated non-Hodgkin's lymphoma of B-cell origin, Hodgkin's disease, acute leukemia, and systemic lupus erythematosus: a serologic and molecular analysis.
    Mitarnun W, Pradutkanchana J, Takao S, Saechan V, Suwiwat S, Ishida T.
    J Med Assoc Thai; 2002 May 01; 85(5):552-9. PubMed ID: 12188384
    [Abstract] [Full Text] [Related]

  • 20. Recognition of Epstein-Barr virus-associated gastric carcinoma cells by cytotoxic T lymphocytes induced in vitro with autologous lymphoblastoid cell line and LMP2-derived, HLA-A24-restricted 9-mer peptide.
    Okugawa K, Itoh T, Kawashima I, Takesako K, Mazda O, Nukaya I, Yano Y, Yamamoto Y, Yamagishi H, Ueda Y.
    Oncol Rep; 2004 Oct 01; 12(4):725-31. PubMed ID: 15375491
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.